Morgan Stanley Coll Plant Biotechnologies LTD Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Morgan Stanley holds 1 shares of CLGN stock, worth $2. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$2
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CLGN
# of Institutions
21Shares Held
2.66MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC547KShares$1.41 Million0.08% of portfolio
-
Pinnacle Associates LTD507KShares$1.31 Million0.01% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.2 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$713,1892.69% of portfolio
-
Heights Capital Management, Inc San Francisco, CA275KShares$709,7110.1% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $28.6M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...